Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H23N3O2 |
Molecular Weight | 361.4369 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CN(CCC3=CC=C(NC(C)=O)C=C3)C[C@@]1([H])C4=CC(=CC=C4OC2)C#N
InChI
InChIKey=ZDZWIQDJFWTDAM-GHTZIAJQSA-N
InChI=1S/C22H23N3O2/c1-15(26)24-19-5-2-16(3-6-19)8-9-25-12-18-14-27-22-7-4-17(11-23)10-20(22)21(18)13-25/h2-7,10,18,21H,8-9,12-14H2,1H3,(H,24,26)/t18-,21+/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
S-33138
Created by
admin on Sat Dec 16 11:36:45 GMT 2023 , Edited by admin on Sat Dec 16 11:36:45 GMT 2023
|
PRIMARY | A preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent; it does not interact with histamine H1 and muscarinic receptors. | ||
|
9841864
Created by
admin on Sat Dec 16 11:36:45 GMT 2023 , Edited by admin on Sat Dec 16 11:36:45 GMT 2023
|
PRIMARY | |||
|
245514-32-3
Created by
admin on Sat Dec 16 11:36:45 GMT 2023 , Edited by admin on Sat Dec 16 11:36:45 GMT 2023
|
PRIMARY | |||
|
DJ7ZL6XVM7
Created by
admin on Sat Dec 16 11:36:45 GMT 2023 , Edited by admin on Sat Dec 16 11:36:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY